[go: up one dir, main page]

CN106693034A - Preparation method of pollution-free surgical dressing for sterilizing and stopping bleeding - Google Patents

Preparation method of pollution-free surgical dressing for sterilizing and stopping bleeding Download PDF

Info

Publication number
CN106693034A
CN106693034A CN201710189084.1A CN201710189084A CN106693034A CN 106693034 A CN106693034 A CN 106693034A CN 201710189084 A CN201710189084 A CN 201710189084A CN 106693034 A CN106693034 A CN 106693034A
Authority
CN
China
Prior art keywords
parts
amnion
vacuum
freeze
hours
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201710189084.1A
Other languages
Chinese (zh)
Inventor
罗静峰
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN201710189084.1A priority Critical patent/CN106693034A/en
Publication of CN106693034A publication Critical patent/CN106693034A/en
Pending legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/40Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing ingredients of undetermined constitution or reaction products thereof, e.g. plant or animal extracts
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/42Use of materials characterised by their function or physical properties
    • A61L15/44Medicaments
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/42Use of materials characterised by their function or physical properties
    • A61L15/46Deodorants or malodour counteractants, e.g. to inhibit the formation of ammonia or bacteria
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/402Anaestetics, analgesics, e.g. lidocaine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/404Biocides, antimicrobial agents, antiseptic agents
    • A61L2300/406Antibiotics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/412Tissue-regenerating or healing or proliferative agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2400/00Materials characterised by their function or physical properties
    • A61L2400/04Materials for stopping bleeding

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Hematology (AREA)
  • Engineering & Computer Science (AREA)
  • Materials Engineering (AREA)
  • Epidemiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Botany (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Materials For Medical Uses (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

本发明涉及一种无污染的杀菌止血医用敷料的制备方法,采用分阶段的真空冷冻干燥技术处理羊膜并浸渍中药提取物,制备出一种有效的杀菌止血的医用敷料,可以广泛应用于各种不同程度的创面的治疗,与现有技术相比,本发明制备得到的医用敷料止血止痛、促进愈合,并且对人体无副作用,使用安全。本发明的制备方法简单易行,成本低,无污染。The invention relates to a method for preparing a non-polluting bactericidal and hemostatic medical dressing. The amniotic membrane is processed by staged vacuum freeze-drying technology and soaked in traditional Chinese medicine extracts to prepare an effective bactericidal and hemostatic medical dressing, which can be widely used in various Compared with the prior art, the medical dressing prepared by the invention stops bleeding, relieves pain, promotes healing, has no side effects on human body, and is safe to use for the treatment of wounds in different degrees. The preparation method of the invention is simple, easy to implement, low in cost and pollution-free.

Description

一种无污染的杀菌止血医用敷料的制备方法A kind of preparation method of pollution-free bactericidal hemostatic medical dressing

本发明是申请号:2015104682485,申请日:2015-08-03,发明名称:一种杀菌止血的医用敷料的制备方法的分案申请。The present invention is a divisional application of application number: 2015104682485, application date: 2015-08-03, and invention name: a preparation method of a bactericidal and hemostatic medical dressing.

技术领域technical field

本发明属于医用材料领域,具体涉及一种无污染的杀菌止血医用敷料的制备方法。The invention belongs to the field of medical materials, in particular to a method for preparing a non-polluting bactericidal and hemostatic medical dressing.

背景技术Background technique

在人们日常生活中,烧伤、烫伤时常发生,造成各种深度不同的创面,并极易造成感染,导致各种并发症,因此用于该领域的有效的医用敷料的研制是急需解决的问题。羊膜由于自身独有的特性受到国内外学者关注,羊膜从细胞滋养层衍化而来,是胚胎双层膜的内层,由上皮细胞层,基底膜和无血管基质组成,羊膜中包含多种胶原蛋白以及层粘连蛋白、纤连蛋白、糖胺聚糖、透明质酸等。正是这些活性物质的存在,可以促进上皮细胞的黏附移行,诱导上皮分化,防止上皮凋亡,使得羊膜充当一种“可移植的基底膜”来促进上皮化。此外,羊膜基质中还包含有很多生长因子,比如神经生长因子(NGF),肝细胞生长因子(HGF),角质细胞生长因子(KGF),转化生长因子-α(TGF-α),转化生长因子-β1(TGF-β1),表皮生长因子(EGF),碱性成纤维细胞生长因子(bFGF)等等,能够促进眼表上皮化、减轻炎性反应、抑制纤维组织增生和新生血管形成。因此,近年来羊膜在眼表重建中的应用备受瞩目。In people's daily life, burns and scalds often occur, causing wounds with different depths, and are very easy to cause infection and various complications. Therefore, the development of effective medical dressings for this field is an urgent problem to be solved. Due to its unique characteristics, the amniotic membrane has attracted the attention of scholars at home and abroad. The amniotic membrane is derived from the cytotrophoblast, which is the inner layer of the double membrane of the embryo. It is composed of epithelial cell layer, basement membrane and avascular matrix. The amniotic membrane contains a variety of collagens protein and laminin, fibronectin, glycosaminoglycan, hyaluronic acid, etc. It is the presence of these active substances that can promote the adhesion and migration of epithelial cells, induce epithelial differentiation, and prevent epithelial apoptosis, making the amnion a "transplantable basement membrane" to promote epithelialization. In addition, amnion stroma also contains many growth factors, such as nerve growth factor (NGF), hepatocyte growth factor (HGF), keratinocyte growth factor (KGF), transforming growth factor-α (TGF-α), transforming growth factor -β1 (TGF-β1), epidermal growth factor (EGF), basic fibroblast growth factor (bFGF), etc., can promote ocular surface epithelialization, reduce inflammatory response, inhibit fibrous tissue proliferation and angiogenesis. Therefore, the application of amniotic membrane in ocular surface reconstruction has attracted much attention in recent years.

发明内容Contents of the invention

本发明的目的在于利用羊膜与特定中草药结合共同制备出一种有效的杀菌止血的医用敷料,以解决现有技术中存在的上述问题。The purpose of the present invention is to combine amniotic membrane and specific Chinese herbal medicine to prepare an effective bactericidal and hemostatic medical dressing, so as to solve the above-mentioned problems in the prior art.

本发明采用如下技术方案:一种无污染的杀菌止血医用敷料的制备方法,包括以下步骤:The present invention adopts the following technical scheme: a preparation method of a pollution-free bactericidal and hemostatic medical dressing, comprising the following steps:

(1)消毒杀菌:用生理盐水清洗羊膜后,浸泡于过氧化氢水溶液中2-3h,然后用水清洗干净;将消毒后的羊膜浸泡于含有抗生素的水溶液2~3h;(1) Disinfection and sterilization: After washing the amniotic membrane with normal saline, soak it in aqueous hydrogen peroxide solution for 2-3 hours, and then clean it with water; soak the sterilized amniotic membrane in an aqueous solution containing antibiotics for 2-3 hours;

(2)分阶段真空冷冻干燥:将步骤(1)得到的羊膜置于5~10g/L的海藻酸钠和1~5g/L透明质酸溶液中静置10~15h后,进行真空冷冻干燥,先在2~5℃下预冻2~3h,然后降温到-10~-15℃,冷冻3~5h,在继续降温到-20~-25℃,冷冻3~5h,在继续降温到-40~-50℃,冷冻7~10h,控制羊膜的水分含量在5~10%;(2) Vacuum freeze-drying in stages: place the amniotic membrane obtained in step (1) in a solution of 5-10 g/L sodium alginate and 1-5 g/L hyaluronic acid, let it stand for 10-15 hours, and then carry out vacuum freeze-drying , first pre-freeze at 2-5°C for 2-3 hours, then cool down to -10-15°C, freeze for 3-5 hours, continue to cool down to -20-25°C, freeze for 3-5 hours, and continue to cool down to - 40~-50℃, freeze for 7~10 hours, control the water content of the amniotic membrane at 5~10%;

(3)浸渍中药:将步骤(2)得到的羊膜浸渍在中药提取物中,加热使浸泡温度在30~50℃,浸泡时间为10~15h;其中所述的中药提取物通过以下方法制备得到:按以下质量份取中药药材,大青叶8-10份、蛇床子3-5份、三七3-5份、黄芩1-5份、蒲公英1-3份、野菊花2-3份、金银花1-3份、骨丹3-5份、七里单6-8份、乳香2-3份、没药5-10份、丁香2-5份、红花1-3份、大黄3-5份、甘草3-5份、苍术1-2份,加水煎煮1-2小时,得到的煎煮液经超滤和纳滤后,得到中药精制液,然后加入医用酒精和水混合,调节溶液中酒精浓度为65-70%,并加热至60-70℃得到所述的中药提取物;(3) Soaking Chinese medicine: soak the amniotic membrane obtained in step (2) in the Chinese medicine extract, heat to make the soaking temperature 30-50°C, and the soaking time is 10-15h; wherein the Chinese medicine extract is prepared by the following method : Take Chinese medicinal materials according to the following parts by mass, 8-10 parts of Daqingye, 3-5 parts of Fructus Cnidii, 3-5 parts of Panax notoginseng, 1-5 parts of Scutellaria baicalensis, 1-3 parts of dandelion, 2-3 parts of wild chrysanthemum, Honeysuckle 1-3 parts, Gudan 3-5 parts, Qili Dan 6-8 parts, frankincense 2-3 parts, myrrh 5-10 parts, cloves 2-5 parts, safflower 1-3 parts, rhubarb 3-5 parts 3-5 parts of licorice, 1-2 parts of atractylodes rhizome, add water and decoct for 1-2 hours, the obtained decoction is subjected to ultrafiltration and nanofiltration to obtain the refined liquid of traditional Chinese medicine, and then add medical alcohol and water to mix to adjust the solution The alcohol concentration is 65-70%, and heated to 60-70°C to obtain the Chinese medicine extract;

(4)真空干燥:将步骤(3)处理后的羊膜进行真空干燥处理,温度为60~70℃,干燥时间2-4小时;(4) Vacuum drying: the amniotic membrane treated in step (3) is vacuum-dried at a temperature of 60-70° C., and the drying time is 2-4 hours;

(5)封装灭菌:经过真空干燥后的羊膜进行包装、灭菌即可在常温下保存。(5) Encapsulation and sterilization: the amniotic membrane after vacuum drying is packaged and sterilized to be stored at room temperature.

在本发明的优选的实施方案中,所述过氧化氢水溶液的浓度为2~4g/L。In a preferred embodiment of the present invention, the concentration of the aqueous hydrogen peroxide solution is 2-4 g/L.

在本发明的优选的实施方案中,所述的抗生素选自青霉素、链霉素、庆大霉素中的一种或是两种,其用量分别为50μg/mL、30μg/mL、10μg/mL;In a preferred embodiment of the present invention, the antibiotics are selected from one or both of penicillin, streptomycin, and gentamicin, and the dosages are 50 μg/mL, 30 μg/mL, and 10 μg/mL, respectively. ;

在本发明的优选的实施方案中,所述步骤(4)的真空度为0.01-0.05MPa。In a preferred embodiment of the present invention, the degree of vacuum in step (4) is 0.01-0.05 MPa.

本发明制备的医用敷料可以广泛应用于各种不同程度的创面的治疗,与现有技术相比,本发明具备以下有益效果:The medical dressing prepared by the present invention can be widely used in the treatment of various degrees of wounds. Compared with the prior art, the present invention has the following beneficial effects:

(1)经过长期试验研究,发现采用分阶段的真空冷冻干燥技术,将羊膜在逐级降低的温度下冷冻干燥,阶梯式降温,能够最大程度的保留了其胶原和活性因子成分,使得羊膜的组成没有受到破坏,经检测,所制得的医用敷料含有Ⅰ型胶原290.1±1.0μg/mg、Ⅲ型胶原356.8±2.0μg/mg,Ⅳ型胶原47.1±1.0μg/mg,肝细胞生长因子71.2±1.0μg/mg,碱性成纤维细胞生长因子56.1±1.0μg/mg;而新鲜羊膜中含Ⅰ型胶原303.5±5.3μg/mg,Ⅲ型胶原384.2±4.5μg/mg,Ⅳ型胶原53.6±1.7μg/mg,肝细胞生长因子89.9±3.2μg/mg,碱性成纤维细胞生长因子71.1±1.0μg/mg。(1) After long-term experimental research, it was found that the use of staged vacuum freeze-drying technology, the amniotic membrane is freeze-dried at a gradually lowered temperature, and the stepwise cooling can retain its collagen and active factor components to the greatest extent, making the amniotic membrane more stable. The composition is not damaged. After testing, the prepared medical dressing contains 290.1±1.0 μg/mg of type I collagen, 356.8±2.0 μg/mg of type III collagen, 47.1±1.0 μg/mg of type IV collagen, and 71.2 μg/mg of hepatocyte growth factor ±1.0μg/mg, basic fibroblast growth factor 56.1±1.0μg/mg; and fresh amniotic membrane contains type Ⅰ collagen 303.5±5.3 μg/mg, type Ⅲ collagen 384.2±4.5 μg/mg, type Ⅳ collagen 53.6± 1.7μg/mg, hepatocyte growth factor 89.9±3.2μg/mg, basic fibroblast growth factor 71.1±1.0μg/mg.

(2)通过浸渍本发明的特定中药配方,使得得到的羊膜敷料能够更有效的止血止痛、促进愈合,并且对人体无副作用,使用安全。(2) By impregnating the specific traditional Chinese medicine formula of the present invention, the obtained amniotic membrane dressing can more effectively stop bleeding, relieve pain, and promote healing, and has no side effects on the human body, and is safe to use.

(3)本发明的制备方法简单易行,成本低,无污染。(3) The preparation method of the present invention is simple, easy to implement, low in cost and non-polluting.

具体实施方式detailed description

以下结合实例对本发明技术方案及其效果作进一步的说明。The technical solutions of the present invention and their effects are further described below in conjunction with examples.

实施例1Example 1

(1)消毒杀菌:用生理盐水清洗羊膜后,浸泡于2g/L过氧化氢水溶液中2h,然后用水清洗干净;将消毒后的羊膜浸泡于含有50μg/mL青霉素的水溶液3h;(1) Disinfection and sterilization: After cleaning the amniotic membrane with physiological saline, soak it in 2g/L hydrogen peroxide aqueous solution for 2 hours, and then wash it with water; soak the sterilized amniotic membrane in an aqueous solution containing 50 μg/mL penicillin for 3 hours;

(2)分阶段真空冷冻干燥:将步骤(1)得到的羊膜置于8g/L的海藻酸钠和5g/L透明质酸溶液中静置10h后,进行真空冷冻干燥,先在3℃下预冻3h,然后降温到-10℃,冷冻5h,在继续降温到-20℃,冷冻5h,在继续降温到-50℃,冷冻8h,控制羊膜的水分含量在7%;(2) Vacuum freeze-drying in stages: put the amniotic membrane obtained in step (1) in a solution of 8g/L sodium alginate and 5g/L hyaluronic acid for 10 hours, then carry out vacuum freeze-drying, first at 3°C Pre-freeze for 3 hours, then cool down to -10°C, freeze for 5 hours, continue to cool down to -20°C, freeze for 5 hours, continue to cool down to -50°C, freeze for 8 hours, and control the moisture content of the amniotic membrane at 7%;

(3)浸渍中药:将步骤(2)得到的羊膜浸渍在中药提取物中,加热使浸泡温度在30℃,浸泡时间为15h;其中所述的中药提取物通过以下方法制备得到:按以下质量份取中药药材,大青叶10份、蛇床子3份、三七4份、黄芩2份、蒲公英2份、野菊花2份、金银花2份、骨丹3份、七里单6份、乳香2份、没药6份、丁香3份、红花2份、大黄3份、甘草3份、苍术1份,加水煎煮2小时,得到的煎煮液经超滤和纳滤后,得到中药精制液,然后加入医用酒精和水混合,调节溶液中酒精浓度为70%,并加热至60℃得到所述的中药提取物;(3) Soaking Chinese medicine: soak the amniotic membrane obtained in step (2) in the Chinese medicine extract, heat to make the soaking temperature 30°C, and the soaking time is 15h; wherein the Chinese medicine extract is prepared by the following method: according to the following mass Take Chinese medicinal materials, 10 parts of Daqingye, 3 parts of Cnidium, 4 parts of Panax notoginseng, 2 parts of Scutellaria baicalensis, 2 parts of Dandelion, 2 parts of wild chrysanthemum, 2 parts of honeysuckle, 3 parts of Gu Dan, 6 parts of Qili Dan, 2 parts of frankincense 6 parts of myrrh, 3 parts of cloves, 2 parts of safflower, 3 parts of rhubarb, 3 parts of licorice, 1 part of atractylodes, add water and decoct for 2 hours, and the obtained decoction is subjected to ultrafiltration and nanofiltration to obtain refined Chinese medicine solution, then add medical alcohol and water to mix, adjust the alcohol concentration in the solution to 70%, and heat to 60°C to obtain the Chinese medicine extract;

(4)真空干燥:将步骤(3)处理后的羊膜进行真空干燥处理,真空度为0.02MPa,温度为70℃,干燥时间2小时;(4) Vacuum drying: the amniotic membrane treated in step (3) is subjected to vacuum drying treatment, the vacuum degree is 0.02MPa, the temperature is 70°C, and the drying time is 2 hours;

(5)封装灭菌:经过真空干燥后的羊膜进行包装、灭菌即可在常温下保存。(5) Encapsulation and sterilization: the amniotic membrane after vacuum drying is packaged and sterilized to be stored at room temperature.

经检测,所制得的医用敷料含有Ⅰ型胶原290.1μg/mg、Ⅲ型胶原356.8μg/mg,Ⅳ型胶原47.1μg/mg,肝细胞生长因子71.2μg/mg,碱性成纤维细胞生长因子56.1μg/mg,与新鲜羊膜的成分较为接近,说明上述制备方法基本没有对羊膜的成分造成破坏,极大程度的保持了其原貌。After testing, the prepared medical dressing contained 290.1 μg/mg type I collagen, 356.8 μg/mg type III collagen, 47.1 μg/mg type IV collagen, 71.2 μg/mg hepatocyte growth factor, and 71.2 μg/mg basic fibroblast growth factor 56.1 μg/mg, which is relatively close to the composition of fresh amniotic membrane, indicating that the above preparation method basically does not damage the composition of amniotic membrane, and maintains its original appearance to a great extent.

将制得的医用敷料用于创面,测试其对创面愈合的影响(率,时间)。选用动物的深II度皮肤烫伤模型作为评价敷料对创面愈合影响的动物模型。The prepared medical dressing was used on the wound surface to test its effect on wound healing (rate, time). The animal model of deep second-degree skin burn was selected as the animal model to evaluate the effect of dressing on wound healing.

将雄性Wistar大鼠随机分组,包括自然愈合组、市售常规医用敷料组、本发明医用敷料组,各组观察时相点为伤后3、7、14、21d,每组每时相点10只动物。将大鼠麻醉成功后用80℃水浴烫15秒造成大鼠背部10%深II度皮肤烫伤(病检切片证实),伤后经腹腔给予5ml生理盐水。除自然愈合组外,各组分别用相应敷料覆盖创面。伤后各确定时相点测创面愈合率,先将创面描记在半透明纸上,再以此为模板,将质地均匀的硬纸片剪成同样大小,然后用天平称重,以硬纸片重量间接地表示创面面积大小。按下式计算创面愈合率:创面愈合率(%)=(原始创面面积一未愈合创面面积)/原始创面面积。病理检查,了解创面愈合质量,并根据创面愈合情况确定愈合时间。试验结果显示,本发明医用敷料组,在创面恢复时间上和创面愈合率两方面都优于自然愈合组、市售常规医用敷料组。Male Wistar rats were randomly divided into groups, including the natural healing group, the commercially available conventional medical dressing group, and the medical dressing group of the present invention. only animals. After the rats were successfully anesthetized, scald them in an 80° C. water bath for 15 seconds to cause 10% deep second-degree skin burns on the back of the rats (confirmed by pathological examination sections), and give 5 ml of normal saline through the abdominal cavity after the injury. Except for the natural healing group, each group covered the wound with corresponding dressings. The wound healing rate was measured at each time point after the injury. Firstly, the wound surface was traced on translucent paper, and then as a template, the cardboard with uniform texture was cut into the same size, and then weighed with a balance. The weight indirectly indicates the size of the wound area. The wound healing rate was calculated according to the formula: wound healing rate (%)=(original wound area−unhealed wound area)/original wound area. Pathological examination, to understand the quality of wound healing, and determine the healing time according to the wound healing. The test results show that the medical dressing group of the present invention is superior to the natural healing group and the commercially available conventional medical dressing group in terms of wound recovery time and wound healing rate.

本发明并非限定于所述特定的实施例及说明,并且不脱离在权利要求范围中所请求的本发明的要点,本发明所属的技术领域具有通常知识的人员均可进行各种变形,并且所述变形所属于本发明的保护范围。The present invention is not limited to the specific embodiments and descriptions, and without departing from the gist of the present invention claimed in the scope of the claims, various modifications can be made by those with ordinary knowledge in the technical field to which the present invention belongs, and the The above-mentioned deformation belongs to the protection scope of the present invention.

Claims (1)

1. a kind of preparation method of free of contamination bactericidal haemostatic medical dressing, it is characterised in that comprise the following steps:
(1) disinfection:After cleaning amnion with physiological saline, 2-3h in aqueous hydrogen peroxide solution is soaked in, is then cleaned with water Totally;Amnion after sterilization is soaked in the 2~3h of the aqueous solution containing antibiotic;
(2) vacuum freeze drying stage by stage:The amnion that step (1) is obtained is placed in the sodium alginate and 1~5g/L of 5~10g/L After standing 10~15h in hyaluronic acid solution, vacuum freeze drying is carried out, first 2~3h of pre-freeze at 2~5 DEG C, then lowers the temperature To -10~-15 DEG C, 3~5h is freezed, continuing to cool to -20~-25 DEG C, freeze 3~5h, continuing to cool to -40~-50 DEG C, 7~10h is freezed, the moisture of amnion is controlled 5~10%;
(3) Chinese medicine is impregnated:The amnion that step (2) is obtained is immersed in Chinese medical extract, heating makes soaking temperature 30~50 DEG C, soak time is 10~15h;Wherein described Chinese medical extract is prepared by the following method and obtains:Taken by following mass parts Chinese medicinal material, folium isatidis 8-10 parts, frutus cnidii 3-5 parts, pseudo-ginseng 3-5 parts, root of large-flowered skullcap 1-5 parts, dandelion 1-3 parts, chrysanthemum indicum 2-3 Part, honeysuckle 1-3 parts, 3-5 parts of bone pellet, Fructus Tribuli 6-8 parts, frankincense 2-3 parts, myrrh 5-10 parts, cloves 2-5 parts, safflower 1-3 Part, rheum officinale 3-5 parts, Radix Glycyrrhizae 3-5 parts, rhizoma atractylodis 1-2 parts, add water to cook 1-2 hours, after the decoction liquor for obtaining is through ultrafiltration and nanofiltration, Purification of tcm liquid is obtained, medicinal alcohol and water mixing is subsequently adding, alcohol concentration is 65-70% in regulation solution, and is heated to 60-70 DEG C obtains described Chinese medical extract;
(4) it is vacuum dried:Amnion after step (3) treatment is carried out into vacuum drying treatment, temperature is 60~70 DEG C, drying time 2-4 hours;
(5) encapsulation sterilizing:Preserved at normal temperatures by the amnion after vacuum drying is packed, sterilized;
The concentration of the aqueous hydrogen peroxide solution is 2~4g/L;
The vacuum of the step (4) is 0.01-0.05MPa.
CN201710189084.1A 2015-08-03 2015-08-03 Preparation method of pollution-free surgical dressing for sterilizing and stopping bleeding Pending CN106693034A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201710189084.1A CN106693034A (en) 2015-08-03 2015-08-03 Preparation method of pollution-free surgical dressing for sterilizing and stopping bleeding

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CN201710189084.1A CN106693034A (en) 2015-08-03 2015-08-03 Preparation method of pollution-free surgical dressing for sterilizing and stopping bleeding
CN201510468248.5A CN104998294B (en) 2015-08-03 2015-08-03 A kind of preparation method of the medical dressing of bactericidal haemostatic

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
CN201510468248.5A Division CN104998294B (en) 2015-08-03 2015-08-03 A kind of preparation method of the medical dressing of bactericidal haemostatic

Publications (1)

Publication Number Publication Date
CN106693034A true CN106693034A (en) 2017-05-24

Family

ID=54371324

Family Applications (5)

Application Number Title Priority Date Filing Date
CN201710189024.XA Withdrawn CN106693033A (en) 2015-08-03 2015-08-03 Preparation method of sterilizing and blooding-stopping medical dressing with low cost
CN201710189023.5A Withdrawn CN106729935A (en) 2015-08-03 2015-08-03 A kind of preparation method of the bactericidal haemostatic medical dressing using safety
CN201710189022.0A Withdrawn CN106822981A (en) 2015-08-03 2015-08-03 A kind of preparation method of the bactericidal haemostatic medical dressing having no side effect
CN201510468248.5A Active CN104998294B (en) 2015-08-03 2015-08-03 A kind of preparation method of the medical dressing of bactericidal haemostatic
CN201710189084.1A Pending CN106693034A (en) 2015-08-03 2015-08-03 Preparation method of pollution-free surgical dressing for sterilizing and stopping bleeding

Family Applications Before (4)

Application Number Title Priority Date Filing Date
CN201710189024.XA Withdrawn CN106693033A (en) 2015-08-03 2015-08-03 Preparation method of sterilizing and blooding-stopping medical dressing with low cost
CN201710189023.5A Withdrawn CN106729935A (en) 2015-08-03 2015-08-03 A kind of preparation method of the bactericidal haemostatic medical dressing using safety
CN201710189022.0A Withdrawn CN106822981A (en) 2015-08-03 2015-08-03 A kind of preparation method of the bactericidal haemostatic medical dressing having no side effect
CN201510468248.5A Active CN104998294B (en) 2015-08-03 2015-08-03 A kind of preparation method of the medical dressing of bactericidal haemostatic

Country Status (1)

Country Link
CN (5) CN106693033A (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107349335A (en) * 2017-06-13 2017-11-17 吉林省拓华生物科技有限公司 One kind carries medicine membrane film and its production and use
CZ307603B6 (en) * 2017-12-27 2019-01-02 BioHealing k.s. A method for preparing amniotic membrane-based material and a material obtainable by this method
CN109045143A (en) * 2018-10-17 2018-12-21 佛山市妇幼保健院 A kind of manufacturing method of Chinese medicine perineum ice compress pad
CN112891062B (en) * 2021-02-26 2022-05-17 河南亚都实业有限公司 A kind of multifunctional nanofiber-based composite hemostatic patch and preparation method thereof
CN114009541B (en) * 2021-11-03 2024-02-13 广西壮族自治区亚热带作物研究所(广西亚热带农产品加工研究所) Passion fruit tea and processing method thereof
CN114042185A (en) * 2021-11-18 2022-02-15 江苏洁乐医用敷料有限公司 Preparation method of medical dressing for sterilization and hemostasis
CN116603092A (en) * 2023-05-11 2023-08-18 苏州晟旺新材料科技有限公司 Self-absorbing antibacterial and healing-promoting medical dressing based on helical fiber structure

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4361552A (en) * 1980-09-26 1982-11-30 Board Of Regents, The University Of Texas System Wound dressing
CN1608681A (en) * 2003-10-17 2005-04-27 胡杰 Biological wound dressing
CN1943796A (en) * 2006-10-20 2007-04-11 关志广 The preparation method of the radiant crosslink porous reticular cells amnionic hydro gel dressing and its preparation method

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1088118A (en) * 1992-12-15 1994-06-22 吕平 Medical protective tectorial membrane for surfaces of wound
AUPQ196799A0 (en) * 1999-08-02 1999-08-26 Pinfold, Ann Method of preservation of amnion and uses thereof
WO2007013331A1 (en) * 2005-07-25 2007-02-01 Arblast Co., Ltd. Sheet-like composition
US20140186461A1 (en) * 2012-09-10 2014-07-03 Alpha Tissue, Inc. Human Amniotic Membrane Lyophilized Grafts

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4361552A (en) * 1980-09-26 1982-11-30 Board Of Regents, The University Of Texas System Wound dressing
CN1608681A (en) * 2003-10-17 2005-04-27 胡杰 Biological wound dressing
CN1943796A (en) * 2006-10-20 2007-04-11 关志广 The preparation method of the radiant crosslink porous reticular cells amnionic hydro gel dressing and its preparation method

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
梁婧等: "人羊膜对创面愈合的促进作用", 《中国美容医学》 *

Also Published As

Publication number Publication date
CN106729935A (en) 2017-05-31
CN106693033A (en) 2017-05-24
CN104998294B (en) 2017-11-14
CN104998294A (en) 2015-10-28
CN106822981A (en) 2017-06-13

Similar Documents

Publication Publication Date Title
CN106693034A (en) Preparation method of pollution-free surgical dressing for sterilizing and stopping bleeding
CN102091203B (en) External traditional Chinese medicine preparation for treating refractory wound and preparation method thereof
CN106728727A (en) It is a kind of to treat ointment of sore and preparation method thereof
CN108939140A (en) Composition for hemostasis and medical hemostatic dressing
CN101837082B (en) Chinese preparation for treating burn without leaving scar
CN101406589B (en) Chinese medicine using desiccation exposition method for treating burn
CN115998636A (en) Gel mask containing recombinant humanized collagen and preparation method thereof
CN105251040A (en) Absorbable medical anti-infective suture line and preparation method
CN104225258A (en) Traditional Chinese medicine composition for promoting wound healing
CN110507558A (en) A kind of hyaluronic acid mask liquid for wound repair and preparation method thereof
CN105920654A (en) Burn dressing applicable to department of burn and having antibacterial effect
CN113197844A (en) Scar-free tissue regeneration promoting paste
CN108478848A (en) A kind of antibiotic property medical hemostatic degreasing cotton gauze and preparation method thereof
CN114931662B (en) Skin care dressing and preparation method thereof
KR20220105717A (en) Intraviginal hydrogel composition
RU2329822C1 (en) Antiseptic, anti-inflammatory, analgesic
CN116492402B (en) A Chinese medicine composition for wound repair
CN105561382A (en) Dendrobium officinale liquid woundplast and preparation method thereof
CN116726127B (en) A traditional Chinese medicine gel for repairing wound surface after anal fistula surgery and preparation method thereof
CN108355130A (en) It is a kind of to treat psoriasic temperature sensitive type collagen composite antiphlogistic gel spray and preparation method thereof
CN107929382B (en) Traditional Chinese medicine liquid preparation for repairing postoperative scars
CN116036149A (en) Preparation method and application of nano-scale small molecular fruit nucleic acid ester composite antibacterial gel
CN105362675A (en) Emulsifiable paste for treating plasmacellular mastitis and preparation method thereof
CN113144176A (en) Skin wound repair composition containing plant extract and preparation method thereof
ES2908121A1 (en) Cream for the treatment of ulcers that occur in the skin (Machine-translation by Google Translate, not legally binding)

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
WD01 Invention patent application deemed withdrawn after publication

Application publication date: 20170524

WD01 Invention patent application deemed withdrawn after publication